Lamuno System: Fast & Accurate PRL/AMH Results

PRL and AMH: Clinical Significance and Diagnostic Challenges

Prolactin (PRL) and Anti-Müllerian Hormone (AMH) are critical indicators for assessing reproductive endocrine health and fertility. Abnormal elevation of PRL can lead to menstrual disorders, infertility, and galactorrhea syndrome, while AMH levels directly reflect ovarian reserve function, playing a vital role in female fertility assessment, Diagnosis of polycystic ovary syndrome (PCOS), and formulation of assisted reproductive strategies. Traditional detection methods have limitations in speed, multi-index joint detection capability, and standardization, highlighting the urgent need for a new generation of diagnostic solutions that balance accuracy, efficiency, and integration.

Precision Quantification and Rapid Testing Advantages

The new-generation multi-channel Immunofluorescence detection system can simultaneously complete the quantitative analysis of PRL, AMH, and multiple other hormones within 15 minutes, with a sensitivity as high as 0.1 ng/mL and specificity exceeding 98%, effectively supporting earlier and more precise subtyping and intervention of reproductive endocrine diseases in clinical practice. Core advantages of the system include:

Efficient screening in reproductive centers:

Suitable for initial infertility clinic screening and dynamic ovarian function assessment.

Multi-index joint diagnosis:

A single test can simultaneously provide results for PRL, AMH, and other related hormones, aiding in precise traceability of causes.

Health management for high-risk groups:

Enables rapid risk assessment and long-term follow-up for individuals with PCOS, premature ovarian insufficiency, and hyperprolactinemia.

Multi-Scenario Application and End-to-End Management

Application in Reproductive Medicine Centers and Obstetrics & Gynecology

Infertility etiology screening:

AMH <1.1 ng/mL suggests decreased ovarian reserve, PRL >25 ng/mL requires investigation for pituitary tumors and endocrine disorders.

Pre-IVF assessment:

Customize ovulation induction protocols based on AMH levels to improve egg retrieval and transplantation success rates.

Application in Endocrinology and Health Management

Pubertal development assessment and perimenopausal management:

Enables early warning of declining ovarian function.

Dynamic therapeutic monitoring:

Tracks efficacy of PRL suppression therapy and ovarian function-regulating medications.

Public Health and Population Health Research

Large-scale reproductive health surveys and epidemiological analysis in women of childbearing age.

Construction of regional health databases to inform public health policy development.

Multiplex Immunofluorescence Detection System (Lamuno) Significantly Enhances Diagnostic Efficiency and Reliability

Rapid point-of-care testing: Compact and lightweight device (only 1.5kg), supports various sample types including whole blood/serum/plasma, suitable for outpatient, emergency, and primary care settings.

Parallel multi-assay testing: 10 independent detection channels can run PRL, AMH, sex hormones, and other tests simultaneously.

No professional operation required: Integrated test card design with built-in quality control and automatic calibration reduces human error.

Sample type: Serum/Plasma/Capillary whole blood (50μL)
Detection time: ≤15 minutes
The system can be operated safely without professional background, greatly enhancing clinical applicability.

AEHEALTH LIMITED, is the fast growing POCT company. Manufacture and sales of rapid diagnostic reagents and related equipment in IVD field.

The product application is covering areas like small clinics, ambulances, customs, ICU, homes, natural disaster rescue, third- party laboratories, etc. To achieve the stability of quanlity control, Aehealth obtained multiple certifications like ISO13485 and CE MARK for the quality control management system.